Population pharmacokinetics of levofloxacin: a systematic review
Abstract
Abstract Levofloxacin is an effective anti-infective agent for the treatment of infectious diseases. However, the marked interindividual variability in levofloxacin pharmacokinetics (PKs) across different populations introduces uncertainty regarding its clinical efficacy and safety. This review aims to comprehensively summarize population pharmacokinetic (PopPK) studies of levofloxacin and to elucidate the covariates that significantly influence its PKs. PubMed, Web of Science, China National Knowledge Infrastructure, and Wanfang databases were searched from database inception to October 2025. A total of 20 studies from 15 countries were finally included and PopPK data were extracted. One-compartment and two-compartment models were applied in 12 and 8 studies, respectively. The estimated weight-normalized clearance (CL) of levofloxacin varied widely, ranging from 0.07 L/h/kg to 0.39 L/h/kg, with a median value of 0.13 L/h/kg. Pediatric patients appeared to clear levofloxacin faster than adults, whereas the elderly exhibited the slowest CL. The most frequently identified covariates affecting levofloxacin CL were renal function, age, weight, pregnancy, and human immunodeficiency virus infection status. The variability in volume of distribution was primarily explained by weight, gender, and aspartate aminotransferase. Large, multicenter, and prospective PopPK studies are warranted to elucidate the PKs of levofloxacin, thus facilitating model-informed precision dosing in…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.